Swiss pharma group Roche reported an increase in their global sales in the first half of the year by 5 percent, at a constant exchange rate, reaching CHF 22.9 billion due to the increased demand for cancer and autoimmune drugs, reports a press relese. According to Severin Schwan, Roche CEO, the good results are due to the performance of the cancer drugs, especially those against breast cancer, and the diagnostic division. The R&D division reported major progress as well both in Pharma and Diagnostic areas. )…) Considering the performance of Roche Group over the first six months, I am sure we will meet our targets for 2014,” stressed Schwan. For the current year, Roche forecasts an increase in sales of about 5 percent, for a constant exchange rate and higher dividends.
Teodorovici: Romania to receive approval from EC on 2014-2020 Operational Programme on Competitiveness until Tuesday
Traian Basescu-Klaus Iohannis exchange baton at the Cotroceni Palace: Romania’s President-elect to officially take over his presidential prerogatives on Sunday
In end-term stocktaking review, Costoiu announces project to build International Centre for Advanced Studies in the Danube Delta
Commemorative concert marking 25 years since Romanian Revolution on Mozart scores, at Romanian Athenaeum
The Nine O’Clock Supplement
Nine O’Clock Announcements
5, Intrarea Armasului, District 1, Bucharest, Telephone: 317.71.36 / 317.71.35, Fax: 317.71.33 / 317.71.39
Nine O`clock Ads
Subscribe to RSS
Subscribe to RSS or enter you email to receive newsletter for news, articles, and updates about what's new.